Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention

키워드

참고문헌 (12)

1. ADVANCE Collaborative Group, "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes", N Engl J Med, 358, pp.2560~2572 (2008)
2. Action to Control Cardiovascular Risk in Diabetes Study Group, "Effects of intensive glucose lowering in type 2 diabetes", N Engl J Med, 358, pp.2545~2559 (2008)
3. Currie CJ, "Survival as a function of HbA(1c)in people with type 2 diabetes : a retrospective cohort study", Lancet, 375, pp.481~489 (2010)
4. Huang ES, "Glycemic control, complications, and death in older diabetic patients : the diabetes and aging study", Diabetes Care, 34, pp.1329~1336 (2011)
5. Connelly KA, "Cardiovascular implications of hypoglycemia in diabetes mellitus", Circulation, 132, pp.2345~2350 (2015)
6. Hwang JK, "Glycemic control status after percutaneous coronary intervention and longterm clinical outcomes in patients with type 2 diabetes mellitus", Circ Cardiovasc Interv, 10, pp.e004157~ (2017)
7. Corpus RA, "Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention", J Am Coll Cardiol, 43, pp.8~14 (2004)
8. Lemesle G, "Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation", Am J Cardiol, 104, pp.41~45 (2009)
9. Funamizu T, "Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study", Cardiovasc Diabetol, 19, pp.21~ (2020)
10. Baber U, "Hemoglobin A1c and cardiovascular outcomes following percutaneous coronary intervention : insights from a large single-center registry", JACC Cardiovasc Interv, 14, pp.388~397 (2021)
11. Jaekyung Bae, "Long-term effects of the mean hemoglobin A1c levels after percutaneous coronary intervention in patients with diabetes", The Korean Journal of Internal Medicine, 36(6), pp.1365~1376 (2021), 대한내과학회[DOI]
12. American Diabetes Association, "Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2021", Diabetes Care, 44(Suppl 1), pp.S111~S124 (2021)

관련 논문AI추천